Deep phenotyping of human brain organoid models of autism spectrum disorder to unravel disease heterogeneity and develop biomarkers and treatments

  • Post author:
  • Post category:

Research Objective We will uncover pathways through which ASD mutations cause disease and close the gap from disease research to therapeutic testing using organoids, primary human neurons, machine learning and…

Continue ReadingDeep phenotyping of human brain organoid models of autism spectrum disorder to unravel disease heterogeneity and develop biomarkers and treatments

Immune cloaking of human stem cell-derived insulin-producing cells for curative cell therapy without immunosuppression

  • Post author:
  • Post category:

Research Objective The goal of our project is to generate cells for replacement therapy in patients that have reduced ability to trigger the immune response in the recipient and therefore…

Continue ReadingImmune cloaking of human stem cell-derived insulin-producing cells for curative cell therapy without immunosuppression

Modeling of GATAD2B-associated neurodevelopmental disorder and NuRDopathies: Investigation of cellular & molecular anomalies altering neurodevelopment

  • Post author:
  • Post category:

Research Objective Human and animal models of NuRD-deficiency will identify NuRD-subtype function in context of neurogenesis. Multi-omic studies will identify/quantify molecular and cellular changes in NuRD-deficiency. Impact NuRD-deficiency causes several…

Continue ReadingModeling of GATAD2B-associated neurodevelopmental disorder and NuRDopathies: Investigation of cellular & molecular anomalies altering neurodevelopment

Modeling and understanding alveolar hypoplasia in Down syndrome using iPSCs-derived alveolar type II cells

  • Post author:
  • Post category:

Research Objective Understanding alveolar progenitor cell defects in T21 and the genes/pathways associated with them will allow for developing therapeutic approaches for individuals with DS. Impact Although trisomy 21 affects…

Continue ReadingModeling and understanding alveolar hypoplasia in Down syndrome using iPSCs-derived alveolar type II cells